Co-Editors-in-Chief

Julie M. Vose, MD, MBA
Neumann M. and Mildred E. Harris Professor
Chief, Hematology/Oncology
University of Nebraska Medical Center

Vose has been a member of the faculty at University of Nebraska Medical Center (UNMC) since she completed her fellowship there in 1990. She currently serves as the chief of the oncology/hematology division in the Department of Internal Medicine at UNMC and Oncology Chief for Nebraska Medicine. Known internationally as a leading expert in the treatment of patients with lymphoma, Vose is actively involved in various novel clinical trials for patients with hematologic malignancies.

Howard S. Hochster, MD
Distinguished Professor of Medicine, Rutgers Robert Wood Johnson Medical School
Associate Director for Clinical Research, Rutgers Cancer Institute of New Jersey
Director of Oncology Research, RWJBarnabas Health

Hochster, a graduate of the Yale School of Medicine, completed an internship, residency, and fellowship in Hematology-Oncology at NYC Health + Hospitals/Bellevue and NYU Langone Medical Center. Hochster is a part of the Rutgers Cancer Institute of New Jersey, serving as the associate director for clinical research and director of gastrointestinal (GI) oncology. He also serves as the director of oncology research at RWJBarnabas Health. Hochster served for eight years as a member of the National Cancer Institute (NCI) Colon Task Force and also as a member of the NCI GI Steering for 6 years. Also recently serving as GI Committee chair of the SWOG cooperative group, he has played an integral role in many of the studies that have set standards for pioneering new treatments in cancer care.